# Minuteman Therapeutics

Source: https://onco.cc/companies/minuteman-therapeutics/  
OnCo record `minuteman-therapeutics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Minuteman Therapeutics develops oncolytic viruses engineered against an individual patient's tumour, matching the virus to the biology of that person's cancer.

## Summary

Oncolytic viruses infect and kill cancer cells and alert the immune system to them; talimogene laherparepvec is the approved example. Minuteman's stated approach is personalised: an oncolytic virus designed against the individual patient's tumour rather than one product for all. It is an Even One Ventures portfolio company with no published trials.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Also known as: Minuteman Tx
- Tags: startup; evenone-portfolio; oncology
- HQ: United States (head office not published)
- Type: biotech
- Website: https://minuteman.bio/

## Sources

- Official website: https://minuteman.bio/
- Even One Ventures portfolio: https://evenone.ventures/

## Connected records

- technologies: [Oncolytic viruses](https://onco.cc/technologies/oncolytic-virus/)
- companies: [Even One Ventures](https://onco.cc/companies/evenone-ventures/)

---
JSON: https://onco.cc/api/v1/entities/minuteman-therapeutics.json